SneakPeek Investments

SneakPeek, a brand of Gateway Genomics (now a subsidiary of CooperSurgical), is a leading genomics and consumer healthcare company specializing in early-stage prenatal DNA testing. The company is best known for its SneakPeek Early Gender DNA Test, which enables expecting parents to determine fetal sex as early as six weeks into pregnancy with over 99% accuracy. Utilizing advanced molecular diagnostics such as quantitative PCR (qPCR) and next-generation sequencing to detect fetal DNA in maternal blood, SneakPeek has established itself as a market leader in the reproductive health space. Following its acquisition by The Cooper Companies in 2022, the company has expanded its portfolio to include pediatric trait testing and nutritional genomics. SneakPeek operates a dual business model, offering direct-to-consumer kits and a clinical network of over 4,000 healthcare providers.